Ana Luisa Corona-Nakamura

ORCID: 0000-0003-3655-0322
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bacterial Infections and Vaccines
  • Herpesvirus Infections and Treatments
  • HIV/AIDS Research and Interventions
  • Cytomegalovirus and herpesvirus research
  • Antibiotic Resistance in Bacteria
  • Infectious Diseases and Tuberculosis
  • HIV/AIDS drug development and treatment
  • Bacterial biofilms and quorum sensing
  • Intestinal and Peritoneal Adhesions
  • Neurological Complications and Syndromes
  • Long-Term Effects of COVID-19
  • Cancer, Hypoxia, and Metabolism
  • Gastrointestinal disorders and treatments
  • Colorectal and Anal Carcinomas
  • Bacterial Identification and Susceptibility Testing
  • Amoebic Infections and Treatments
  • Otolaryngology and Infectious Diseases
  • HIV Research and Treatment
  • Pleural and Pulmonary Diseases
  • Streptococcal Infections and Treatments
  • COVID-19 and Mental Health
  • Salivary Gland Tumors Diagnosis and Treatment
  • Surgical site infection prevention
  • Head and Neck Anomalies
  • Pneumothorax, Barotrauma, Emphysema

Mexican Social Security Institute
2005-2024

Universidad Autónoma de Guadalajara
2018

Universidad de Guadalajara
2018

Creative Research Enterprises (United States)
2018

Secretaría de Salud de Jalisco
2001

Background: Spontaneous pneumomediastinum (SPM) is an uncommon condition in COVID-19 patients. No information about outcome or risk factors available at the time. The aim of this research to report on frequency and spontaneous Materials Methods: An unmatched case-control study was carried out a tertiary health-care facility for patients with COVID-19. Electronic files were reviewed identify confirmed infection by RT-PCR. Univariate analysis used describe demographic data. Mean differences...

10.3389/fmed.2021.662358 article EN cc-by Frontiers in Medicine 2021-04-09

Objectives To describe the prevalence of baseline drug‐resistance mutations, resistance to antiretroviral drugs, and subsequent virological response therapy in treatment‐naïve patients from Mexico with established HIV‐1 infection. Methods Resistance testing was performed on plasma samples antiretroviral‐naïve patients. Data mutations associated drug were obtained using Stanford software ( http://hivdb.stanford.edu ). Results Ninety‐six individuals enrolled study during 2002–2003. Of these,...

10.1111/j.1468-1293.2005.00326.x article EN HIV Medicine 2005-10-28

Herpes zoster (HZ) infection occurs in approximately 10% to 30% of individuals. Visceral neuropathies secondary HZ can cause cystitis and urinary retention. But colonic pseudo-obstruction also occur. Peripheral neuropathy may reveal segmental motor paresis either upper or lower limbs, the abdominal muscles diaphragm. We report case a 62-year-old male patient who presented with distention cutaneous vesicular eruption on left side wall. Plain X-rays computed tomography scan showed distended...

10.12998/wjcc.v6.i6.132 article EN World Journal of Clinical Cases 2018-06-15

Summary Polymorphisms in the CAMP gene (cathelicidin) have not been tested tuberculosis susceptibility. We polymorphisms rs9844812 ( HIF ‐1α:: ARNT binding site) and rs56122065 ) plus rs1800972 DEFB 1 ). SNP was associated with extrapulmonary EPTB a codominant model (genotype CG , P = 0.037, OR 4.82; 95% CI : 0.92–47.42; statistical power, 82%), but PTB 0.101) Mexican population.

10.1111/iji.12080 article EN International Journal of Immunogenetics 2013-08-16

Neurotuberculosis (neuroTB) is a devastating disease, and difficult to diagnose. The aim of this study was analyze the clinical imaging characteristics, outcomes retrospective cohort (2000–2022) hospitalized patients diagnosed with intraspinal intracranial neuroTB. This work designed through clinical, laboratory findings. Variables included: demographic data, history tuberculosis, neurological complications, comorbidities outcomes. Morbi-mortality risk factors were identified by univariate...

10.3390/jcm12134533 article EN Journal of Clinical Medicine 2023-07-06

The aim of this study was to analyze the risk factors and predictors mortality in a retrospective cohort patients with coronavirus disease (COVID-19) who presented central nervous system (CNS) manifestations complications when admitted hospital. Patients hospitalized from 2020 2022 were selected. Demographic variables; history neurological, cardiological pulmonary manifestations; comorbidities; prognostic severity scales; laboratory tests included. Univariate adjusted analyses performed...

10.3390/jcm12124065 article EN Journal of Clinical Medicine 2023-06-15

Nosocomial infectious ventriculitis caused by multidrug-resistant (MDR) Gram-negative bacilli associated with external ventricular drainage (EVD) placement poses a significant mortality burden and hospital costs.

10.3389/fneur.2024.1384206 article EN cc-by Frontiers in Neurology 2024-04-26

Chronic viral infections caused by the human immunodeficiency virus (HIV), hepatitis C (HCV), and B (HBV) are common among patients with end-stage renal disease (ESKD). These were once considered contraindications to kidney transplantation due potential risks associated long-term immunosuppression. Improved management antiviral therapies have changed prognosis survival of this group patients, along an increased experience in transplanting people these infections. We report first successful...

10.1186/s12981-024-00647-y article EN cc-by-nc-nd AIDS Research and Therapy 2024-08-26
Coming Soon ...